Effect of urate-elevating inosine on early Parkinson disease progression: the SURE-PD3 randomized clinical trial

…, KF Callahan, GF Crotty, D Klements, M Kostrzebski… - Jama, 2021 - jamanetwork.com
Importance Urate elevation, despite associations with crystallopathic, cardiovascular, and
metabolic disorders, has been pursued as a potential disease-modifying strategy for …

Efficacy of nilotinib in patients with moderately advanced Parkinson disease: a randomized clinical trial

…, C Venuto, TM Dawson, L Baker, M Kostrzebski… - JAMA …, 2021 - jamanetwork.com
Importance There is a critical need for careful and independent validation of reported
symptomatic efficacy and dopaminergic biomarker changes induced by nilotinib in Parkinson …

[HTML][HTML] Using a smartwatch and smartphone to assess early Parkinson's disease in the WATCH-PD study

…, A Best, J Severson, MA Kostrzebski… - npj Parkinson's …, 2023 - nature.com
Digital health technologies can provide continuous monitoring and objective, real-world
measures of Parkinson’s disease (PD), but have primarily been evaluated in small, single-site …

[HTML][HTML] Mapping relevance of digital measures to meaningful symptoms and impacts in early Parkinson's disease

…, S Jensen-Roberts, M Kostrzebski… - Journal of …, 2023 - content.iospress.com
Mapping Relevance of Digital Measures to Meaningful Symptoms and Impacts in Early
Parkinson’s Disease - IOS Press You are viewing a javascript disabled version of the site …

[HTML][HTML] Relative meaningfulness and impacts of symptoms in people with early-stage Parkinson's disease

…, S Jensen-Roberts, M Kostrzebski… - Journal of …, 2023 - content.iospress.com
… Adams J , Kangarloo T , Tracey B , O’Donnell P , Volfson D , Latzman R , Zach N ,
Alexander R , Bergethon P , Cosman J , Anderson D , Best A , Kostrzebski M , Auinger P …

[HTML][HTML] Towards interpretable speech biomarkers: exploring MFCCs

…, D Volfson, J Glass, R Haulcy, M Kostrzebski… - Scientific Reports, 2023 - nature.com
While speech biomarkers of disease have attracted increased interest in recent years, a
challenge is that features derived from signal processing or machine learning approaches may …

Interactions between enhancer of rudimentary and Notch and deltex reveal a regulatory function of enhancer of rudimentary in the Notch signaling pathway in …

…, AC Phillips, SM Ibach, NK Weber, MA Kostrzebski… - Fly, 2011 - Taylor & Francis
Enhancer of rudimentary, e(r), encodes a small nuclear protein, ER, that has been implicated
in the regulation of pyrimidine metabolism, DNA replication, and cell proliferation. In …

Nilotinib in Patients with Advanced Parkinson's Disease: A Randomized Phase 2A Study (NILO-PD)

…, C Venuto, TM Dawson, L Baker, M Kostrzebski… - medRxiv, 2020 - medrxiv.org
Background Nilotinib, a tyrosine kinase Abelson inhibitor, exhibits neuroprotective effects in
preclinical Parkinson disease (PD) models. Methods This Phase 2A double-blind placebo-…

Towards interpretable speech biomarkers: explaining MFCC2

B Tracey, D Volfson, J Glass, M Kostrzebski, J Adams… - 2023 - researchsquare.com
Speech biomarkers of disease have attracted increased clinical interest in recent years, but
interpretation of clinical features derived from signal processing or machine learning …

A multicenter study using a smartwatch, smartphone, and wearable sensors to assess early Parkinson's disease: Baseline results of the WATCH-PD Study

…, J Cosman, D Anderson, A Best, M Kostrzebski… - 2022 - researchsquare.com
Digital health technologies can provide continuous monitoring and objective, real world
measures of Parkinson’s disease (PD), but have primarily been evaluated in small, single-site …